SCIENTIFIC AND INFORMATION-ANALYTICAL MAGAZINE

ISSN 1024-6177 (Print), ISSN 2618-9615 (Online)

JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Medical Radiology and Radiation Safety. 2021. Vol. 66. № 3. С. 76–81

A.V. Polynovskiy1, D.V. Kuzmichev1, Z.Z. Mammadli1, M.V. Chernich2, J.E. Suraeva1,
J.M. Madjarov1, A.A. Aniskin1, E.S. Kolobanova1

Successful Case of Treatment the Patient with Synchronous Rectal 
and Sigmoid Cancers and Synchronous Lung Metastasis

1N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia

2PET-Technology, Podolsk, Moscow Region, Russia

Contact person: Andrey Vladimirovich Polynovskiy: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract

Colorectal cancers (CRC) takes the leading position in the incidence of morbidity and mortality worldwide. Metastatic CRC in the primary diagnosis ranges from 15 to 35 %. Lung metastasis are the most frequent extraperitoneal manifestation of the metastatic process. Such patients are relatively rare and there are no clear recommendations for their treatment tactics to date. This clinical case describes a successful strategy of using preoperative prolonged chemoradiotherapy on a primary tumor and stereotactic irradiation of lung metastasis, with courses of chemotherapy, with further radical laparoscopic operation, in a patient with disseminated primary multiple rectal cancer, synchronous sigmoid colon cancer and 2 metastatic focuses in both lungs.

Key words:rectal cancer, metastatic, lung metastasis, stereotactic body radiotherapy, ablative radiation therapy, chemoradiotherapy

For citation: Polynovskiy A.V., Kuzmichev D.V., Mammadli Z.Z., Chernich M.V., Suraeva  J.E., Madjarov J.M., Aniskin A.A., Kolobanova E.S. Successful Case of Treatment the Patient with Synchronous Rectal and Sigmoid Cancers and Synchronous Lung Metastasis.  Medical Radiology and Radiation Safety. 2021;66(3):76-81.

DOI: 10.12737/1024-6177-2021-66-3-76-81

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012; Eur J Cancer 2013;49(6):1374–403.
  2. Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005; 10 Suppl 3:40–8. 
  3. Zacharakis M, Xynos I.D, Lazaris A. et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res. 2010;30(2):653–60.
  4. Manfredi S, Lepage C, Hatem C, Coatmeur O. et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9.
  5. Nordholm-Carstensen A, Krarup PM, Jorgensen LN, Wille-Jorgensen PA, et al. On behalf of Danish colorectal Cancer group. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study. Eur J Cancer. 2014; 50:447–56.
  6. Mitry E, Guiu B, Cosconea S, Jooste V, et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010; 59(10):1383–8. 
  7. Tan KK, Lopes Gde L. Jr, Sim R, et al. How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg. 2009; 13:642– 648.
  8. Clark JW, Grothey A. Systemic chemotherapy for nonoperable metastatic colorectal cancer: treatment recommendations. https://www.uptodate.com/contents/systemic-chemotherapy-for-nonoperable-metastatic-colorectal-cancer-treatment-recommendations ?search=systemic-chemotherapy-for-nonoperable-metastatic-colorectal-cancer-treatment& source=search_result&selected Title=1~150&usage_type= default&display_rank=1 (This topic last updated: Jan 13, 2020).
  9. Blalock A. Recent advances in surgery. N Engl J Med. 1944;231:261–7.
  10. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007; 84:324-38.
  11. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997; 113:37–49.
  12. Timmerman RD, Bizekis CS, Pass HI, et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin. 2009;59 P145-70.
  13. Gonzalez M, Ris H.B, Krueger T, Gervaz P. Colorectal cancer and thoracic surgeons: close encounters of the third kind. Expert RevAnticancer Ther. 2012;12:495–503.
  14. Treasure T. Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials. Eur J Cardiothorac Surg. 2008;33P300–2.
  15. Inoue M, Kotake Y, Nakagawa K, Fujiwara K, et al.  Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg. 2000;70:380–3. 
  16. McAfee MK, Allen MS, Trastek VF, Ilstrup DM, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg. 1992; 53:780–5. 
  17. Regnard JF, Grunenwald D, Spaggiari L, et al. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg. 1998; 66:214–8. 
  18. Sakamoto T, Tsubota N, Iwanaga K, Yuki T, et al:ulmonary resection for metastases from colorectal cancer. Chest. 2001; 119:1069–72.
  19. Carballo M, Maish M.S, Jaroszewski D.E, Holmes C.E. Videoassisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study. J Cardiothorac Surg. 2009; 4:13.  
  20. Chao YK, Chang HC, Wu YC, Liu Y.H, et al. Management of lung metastases from colorectal cancer: video-assisted thoracoscopic surgery versus thoracotomy—a casematched study. Thorac Cardiovasc Surg. 2012; 60:398–404. 
  21. Dong S, Zhang L, Li W, Du J, et al. Evaluation of videoassisted thoracoscopic surgery for pulmonary metastases: a metaanalysis. PLoS ONE. 2014; 9:329. 
  22. Nakajima J, Murakawa T, Fukami T, Takamoto S. Is thoracoscopic surgery justified to treat pulmonary metastasis from colorectal cancer?. Interact Cardiovasc Thorac Surg. 2008; 7:212–6. 
  23. Nakas A, Klimatsidas M.N, Entwisle J, Martin-Ucar A.E, et al. Video-assisted versus open pulmonary metastasectomy: the surgeon’s finger or the radiologist’s eye?. Eur J Cardiothorac Surg. 2009; 36:469–74
  24. Ibrahim T, Tselikas L, Yazbeck C, Kattan J. Systemic versus local therapies for colorectal cancer pulmonary metastasis: what to choose and when?. J Gastrointest  Cancer 2016; 47:223-31. 
  25. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27:1386-422. 
  26. Hiraki T, Gobara H, Iguchi T, Fujiwara H, et al. Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer. World J Gastroenterol. 2014; 20:988–96. 
  27. Legras A, Mordant P, Cazes A, Riquet M.. Radiofrequency of lung metastases: should initial pneumothorax predict treatment failure?. Rev Pneumol Clin. 2013; 69:336–9. 
  28.  Matsui Y, Hiraki T, Gobara H, et al. Long-term survival following percutaneous radiofrequency ablation of colorectal lungmetastases. J Vasc Interv Radiol. 2015; 26:303–10.
  29. Schneider T. Thermal ablation of malignant lung tumours. Zentralbl Chir. 2015;140:104–8. 
  30. Takahashi W, Nakajima M, Yamamoto N, et al. Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study. Radiat Oncol. 2014;9:68. 
  31. Yan TD, King J, Sjarif A, Glenn D, et al.  Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol. 2006;13:1588–95. 
  32. Yan TD, King J, Sjarif A, Glenn D, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol. 2006; 13:1529–37.
  33. Nahum Goldberg S, Dupuy D.E. Image-guided radiofrequency tumor ablation: challenges and opportunities—part I. J Vasc Interv Radiol. 2001;12:1021–32.
  34. Hiraki T, Gobara H, Mimura H, et al. Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience. Acta Med Okayama. 2011; 65:287–97.
  35. de Baere T, Tselikas L, Pearson E, et al. Interventional oncology for liver and lung metastases from colorectal cancer: the current state of the art. Diagn Interv Imaging. 2015;96:647–54.
  36. Ferguson J, Alzahrani N, Zhao J, Glenn D, et al. Long term results of RFA to lung metastases from colorectal cancer in 157 patients. Eur J Surg Oncol. 2015;41:690–5
  37. Chi A, Liao Z, Nguyen NP, Xu J, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010;94:1–11
  38. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8:89–91
  39. Carvajal C, Navarro-Martin A, Cacicedo J, Ramos R, et al. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single institution results. J BUON. 2015;20:158–65. 
  40. Filippi AR, Badellino S, Ceccarelli M, et al. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Int J Radiat Oncol Biol Phys. 2015;91:524–9
  41. Takeda A, Sanuki N, Kunieda E. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol. 2014;20:4220–9
  42. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multiinstitutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27:1579–84
  43. Widder J, Klinkenberg TJ, Ubbels JF, Wiegman E.M, et al. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?. Radiother Oncol. 2013;107:409–13
  44. Schlijper RC, Grutters JP, Houben R, et al. What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?. Cancer Treat Rev. 2014;40:60–7.

 PDF (RUS) Full-text article (in Russian)

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 17.03.2021. 

Accepted for publication: 17.03.2021.

 

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2765009
Today
Yesterday
This week
Last week
This month
Last month
For all time
903
4471
23393
18409
72752
75709
2765009
Forecast today
3288

Your IP:216.73.216.43
Visitor Counter

© Журнал "Медицинская радиология и радиационная безопасность" 2020г.

Яндекс.Метрика

Наверх